126 related articles for article (PubMed ID: 28900323)
1. Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma.
Halder S; Mallick D; Mondal P; Roy DS; Halder A; Chakrabarti S
Indian J Med Paediatr Oncol; 2017; 38(2):153-157. PubMed ID: 28900323
[TBL] [Abstract][Full Text] [Related]
2. A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma.
Abood RA; Alomar S; Alharoon SS
J Public Health Afr; 2023 Oct; 14(9):2721. PubMed ID: 37859935
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
Gupta P; Rao S; Bhalla S
Indian J Cancer; 2016; 53(4):505-511. PubMed ID: 28485339
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India.
Patne SCU; Abhilash VB; Dixit VK; Katiyar R; Kumar S; Singh GP
J Clin Diagn Res; 2017 May; 11(5):EC43-EC45. PubMed ID: 28658772
[TBL] [Abstract][Full Text] [Related]
7. HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas.
Rajagopal I; Niveditha SR; Sahadev R; Nagappa PK; Rajendra SG
J Clin Diagn Res; 2015 Mar; 9(3):EC06-10. PubMed ID: 25954623
[TBL] [Abstract][Full Text] [Related]
8. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
Im SA; Lee KE; Nam E; Nam SH; Kim DY; Seong CM; Park HY; Han WS; Seoh JY; Lee SN
Cancer Res Treat; 2003 Apr; 35(2):109-16. PubMed ID: 26680923
[TBL] [Abstract][Full Text] [Related]
10. HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma.
Raj N; Verma D; Kumar A; Rai P; Rao RN
Discoveries (Craiova); 2018 Dec; 6(4):e83. PubMed ID: 32309603
[No Abstract] [Full Text] [Related]
11. Frequency of Human Epidermal Growth Factor Receptor 2 (Her2/Neu) Expression in Gastric Adenocarcinoma in Rehman Medical Institute Peshawar.
Khattak MT; Hassan M; Nasib B; Qamar MA; Javed S; Ali N
J Pak Med Assoc; 2019 Jun; 69(6):788-793. PubMed ID: 31189283
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
[TBL] [Abstract][Full Text] [Related]
13. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
Nadaf AS; Rani H; Dinesh US
Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
[TBL] [Abstract][Full Text] [Related]
14. HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient.
Phan DAT; Nguyen VT; Hua TNH; Ngo QD; Doan TPT; Nguyen ST; Thai AT; Nguyen VT
J Pathol Transl Med; 2017 Jul; 51(4):396-402. PubMed ID: 28625044
[TBL] [Abstract][Full Text] [Related]
15. P1-HNF4α expression negatively correlates with HER2 levels and is associated with good prognosis in gastric adenocarcinoma.
Zhang Z; Hu J; Chu M; Peng X; Zhang Y; Yi W; Ma X
Int J Clin Exp Pathol; 2018; 11(8):4093-4100. PubMed ID: 31949800
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.
Romiti A; Di Rocco R; Milione M; Ruco L; Ziparo V; Zullo A; Duranti E; Sarcina I; Barucca V; D'Antonio C; Marchetti P
Anticancer Res; 2012 Jan; 32(1):115-9. PubMed ID: 22213295
[TBL] [Abstract][Full Text] [Related]
17. [Predictive diagnosis of HER2 in gastric adenocarcinoma].
Daum O; Skálová A; Rozkos T; Laco J
Cesk Patol; 2011 Oct; 47(4):160-3. PubMed ID: 22145214
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
Yao JG; Wang CH; Liu Y
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
[No Abstract] [Full Text] [Related]
20. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]